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Lowe XR, Bhattacharya S, Marchetti F, Wyrobek AJ. Early brain response to low-dose 
radiation exposure involves molecular networks and pathways associated with 
cognitive functions, advanced aging, and Alzheimer’s disease  
Understanding the cognitive and behavioral consequences of brain exposures to low-dose 
ionizing radiation has broad relevance for health risks from medical radiation diagnostic 
procedures, radiotherapy, environmental nuclear contamination, as well as earth orbit and space 
missions. Analyses of transcriptome profiles of murine brain tissue after whole-body radiation 
showed that low-dose exposures (10 cGy) induced genes not affected by high dose (2 Gy), and 
low-dose genes were associated with unique pathways and functions. The low-dose response had 
two major components: pathways that are consistently seen across tissues, and pathways that 
were brain tissue specific. Low-dose genes clustered into a saturated network (p < 10-53) 
containing mostly down-regulated genes involving ion channels, long-term potentiation and 
depression, vascular damage, etc. We identified 9 neural signaling pathways that showed a high 
degree of concordance in their transcriptional response in mouse brain tissue after low-dose 
radiation, in the aging human brain (unirradiated), and in brain tissue from patients with 
Alzheimer’s disease. Mice exposed to high-dose radiation did not show these effects and 
associations. Our findings indicate that the molecular response of the mouse brain within a few 
hours after low-dose irradiation involves the down-regulation of neural pathways associated with 
cognitive dysfunctions that are also down regulated in normal human aging and Alzheimer’s 
disease. 
 
Keywords: low-dose radiation, brain, transcriptome, gene expression, bioinformatics, cognitive 
function, aging, network and pathway bioinformatics; Alzheimer’s disease, human, mouse 
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Introduction 
Ionizing radiation sources are ubiquitous and virtually every one is exposed to low doses from 
cosmic rays, soil radioactivity, and diverse man-made contaminations. The Department of 
Energy defines the upper range of low dose to be 10 cGy. The usage of low-dose radiation is also 
rapidly gaining acceptance in a broad variety of medical diagnostics such at CT scanning (1) 
with doses of 30-70 mGy per head scan series and 20-50 mGy for each abdominal series (2). 
Also, during conventional radiotherapy regimens (e.g., cancer), large tissue volumes receive low-
dose exposures. In 2007, it was estimated that the annual integrated US population dose from all 
medical procedures for the first time exceeded the dose from background sources. Thus, 
understanding the molecular neurological effects of low-dose ionizing radiation has relevance for 
assessing health risks: (a) from medical radiation diagnostics, (b) from side effects of 
radiotherapy, (c) for nuclear energy workers, and (d) to astronauts during space travel.  
 
Epidemiological approaches have been disappointingly ineffective for assessing the health risks 
after low-dose exposures, and linear-no-threshold (LNT) models are applied to estimate the 
health risks from low-dose exposures by extrapolation from high-dose epidemiological data (3).  
Several of the major assumptions underlying the relevance of LNT models to low-dose 
exposures are becoming increasingly controversial: (i) that low-dose radiation elicits the same 
molecular response mechanisms as high-dose but at lower frequencies, and (ii) that, in aggregate, 
the cellular responses to radiation damage are linear in the shape in the low-dose range. Recent 
observations of cellular responses in the low-dose range, such as genomic instability, adaptive 
response and bystander effects, further put into question the validity of the LNT model (4, 5). 
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Tissues differ significantly in their sensitivity to ionizing radiation (6) and significant variation in 
radiation-induced gene expression has been observed among tissues and cell lines, but the 
significance of low-dose exposures for cell survival, tissue damage, and individual health are 
poorly understood (7, 8). The adult brain is generally considered insensitive to ionizing radiation 
due to the relatively radioresistant nature of neurons to cell killing (9), but a small population of 
neuronal precursor cells are relatively sensitive (10-13). Radiation exposures to human brain, 
such as external beam radiotherapy, have been associated with neurological damage and 
cognitive impairment especially in children (14, 15). The neurological deficits of high-dose 
radiation are progressively detrimental over time and are thought to be due to demyelination and 
neural loss (16) with associated neural and cognitive deficiencies (17). Some of these cognitive 
defects have been observed as consequence of impaired neurogenesis following exposure to 
ionizing radiation (11, 18-20). Radiotherapy contains both low-dose and high-dose components. 
As the population of long-term survivors of radiotherapy continues to grow, understanding the 
differential irradiation effects low- and high-dose radiation on cognitive function is emerging as 
a major neurological health concern (21).  
 
Gene expression is a very sensitive indicator of radiation exposure, and low doses are known to 
modulate the transcript profiles in irradiated cells and tissues (22, 23). Previous transcription 
profiling studies of brain tissue have reported significant expression changes following a variety 
of insults (23-27). We reported that doses of 10 cGy induced changes in gene expression in the 
mouse brain that were qualitatively different from those at high dose (2 Gy) and involved neural 
signaling activity (23). A subsequent expression study of rat hippocampal tissue after cranial 
radiation reported that the major responses were centered around Myc and the tumor suppressor 
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gene Tp53 (28). However, neither of these studies employed modern bioinformatics tools for 
pathway and functional analyses. Also, there are rapidly growing numbers of transcriptomic 
databases of physiological and pathological brain conditions (29-33) that can be queried for 
discovering relationships between gene expression alterations and phenotypical changes and 
whether there are common brain responses that are affected by different external insults.   
 
The objectives of our study were to apply advanced bioinformatics analyses of transcript profiles 
obtained from mouse brain tissue after whole body radiation to: (a) identify and characterize the 
molecular interaction networks and pathways induced in brain tissue after 10 cGy low-dose 
exposures (using 2 Gy as a reference dose), and (b) investigate the biological implications of the 
low-dose brain responses by conducting an unbiased search for associations with genetic, 
anatomical, and disease knowledge databases, including transcriptional profiles from human 
brain tissue of aging individuals and Alzheimer’s disease (AD) patients. 
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Materials and Methods 
 
Transcriptome dataset from irradiated mouse brain tissues 
The gene expression data of irradiated mouse brain tissue utilized in the current analyses were 
generated in a previous microarray experiment conducted in our laboratory (23), which was 
reviewed and approved by the IACUC committee of the Lawrence Livermore National 
Laboratory. Briefly, eight to ten week-old B6C3F1/HSD male mice were exposed to whole-body 
gamma-radiation at 0, 10 cGy or 2 Gy using a 137Cs source with a dose-rate of 0.64 Gy min-1. 
Four hours after treatment, mice were euthanized by CO2 inhalation and RNA isolated from 
brain coronal sections (a single section per mouse) and hybridized onto Affymetrix Mgu-74Av2 
gene chips as described (23). The coronal sections included the motor cortex, portions of the 
frontal and parietal lobes, hippocampus, and diencephalons (coordinates 205-305 from the High 
Resolution Mouse Brain Atlas; http://www.hms.harvard.edu./research/brain/atlas.html). 
Statistical analyses of the Affymetrix oligonucleotide array output, conducted as described in 
(23), identified 855 probe sets that were modulated at ≥|1.5| at either 10 cGy or 2 Gy; of these we 
identified for the current study 529 annotated genes based on Unigene ID from NCBI. 
 
The microarray findings of radiation-induced transcriptional changes were confirmed by RT-
PCR for Pcna, Psma4, Csnk2a1 and Sod1 (23). The radiation-induced down-regulation of Grin-1 
was confirmed in the present study by qPCR (Applied Biosystems, Foster City, CA) using the 
Taqman Gene Expression assay #Mm00433785_m1 (Applied Biosystems).  
 
Gene Interaction Networks and Pathway analysis 
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Several bioinformatics tools were used to characterize the radiation-modulated genes for cellular 
processes and biomolecular pathways that were differentially affected by low-dose versus high-
dose exposures: Gene Ontology (GO) enrichment analysis and Ingenuity Pathway Analysis (IPA 
5.0). GO analyses was performed using GO tree machine (34) to generate biological processes, 
molecular function and cellular component categories that were differentially associated with the 
low-dose unique, high-dose unique, and the genes that were in common to both doses. GO 
categories were filtered based upon significance of over-representation of “hits” by using a 
selected threshold for p-values of hypergeometric distribution (p ≤ 0.001). The IPA knowledge 
base includes updated literature information on molecular networks, biological process and an 
extensive library of well characterized signaling and metabolic pathways to understand the 
transcriptional networks, phosphorylation cascades and protein-protein interactions. Radiation 
modulated genes were also analyzed in IPA 5.0 for pathway enrichments with respect to 
reference chip MGu74Av2, to rank the top statistically significant overrepresented canonical 
signaling and metabolic pathways and to determine whether there was significant up- or down-
regulation. The Fisher’s exact t-test was applied to examine the statistical over representation of 
the pathways, using a threshold p-value of ≤ 0.05. 
 
Differentially modulated genes were also overlaid onto the IPA knowledgebase interactome to 
identify networks that were significantly enriched. Generated networks were arranged according 
to IPA score (higher the score, the lower is the probability of finding focus genes in a given 
network due to chance). These networks were further analyzed to identity the major nodes (genes 
in each network with the highest number of interactions with other genes) and the functions 
associated with the genes in the network.    
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Comparisons with other brain gene expression profile datasets related to cognitive 
dysfunction.  
We used L2L microarray tool (ver 2007.1; (35)) to identify other datasets that shared significant 
pathway enrichment with our low-dose and high-dose genes. We divided these analyses into: (a) 
down-regulated low-dose unique genes, (b) up-regulated low-dose unique genes, (c) down-
regulated high-dose unique genes, and (d) up-regulated high-dose unique genes. The search 
using upregulated low-dose genes found no significant hits. The search with the down-regulated 
low-dose genes identified two datasets: (i) a human aging brain dataset generated from human 
postmortem tissue samples of the frontal cortex of 30 individuals, whose age ranged from 26 to 
106 years (36); and, (ii) a human Alzeheimer’s Disease (AD) dataset generated from 
hippocampal tissues from 22 AD subjects of varying severity (Incipient, n = 7; Moderate, n = 8; 
Severe, n = 7) and 9 controls subjects (31). HG-U95Av2 and HG-U133A gene chips 
(Affymetrix) were used for the human aging (36) and AD (31) datasets, respectively. The search 
using down-regulated high-dose genes identified no hits, while the search with up-regulated 
high-dose genes identified the AD but not the aging dataset; however, it identified different 
functions of overlap between the radiation and AD datasets compared to the down-regulated 
low-dose genes (see results). Gene lists from datasets with significant hits were imported into 
IPA and compared with our radiation modulated gene set to identify pathways that were in 
common among the data sets using IPA enrichment analyses, which were conducted as 
mentioned above.   
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When presenting the results of the analyses of the mouse low-dose radiation response, we use the 
mouse gene nomenclature, e.g., Capn3. When we refer to the results of the comparison of the 
three databases, we use the human nomenclature, e.g., CAPN3. 
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Results 
Comparative gene expression profiling after low-dose versus high-dose exposures 
We used transcriptional profiling to contrast the gene functions, gene interaction networks and 
associated biochemical pathways that were modulated in mouse brain tissue after whole body 
low-dose exposure (10 cGy) versus high-dose exposure (2 Gy). Oligonucleotide microarray 
analyses of mRNA collected 4 hours after irradiation identified 396 genes that were modulated 
after low-dose and 406 genes after high-dose exposures (≥|1.5| fold). Of these, 123, 134, and 272 
modulated genes (total 529) were unique to low dose, unique to high dose, and in common 
between both doses, respectively. These findings confirm that low-dose exposures modulates the 
expression of a substantial number of genes that were not affected after high doses and suggest 
that the cellular damage response mechanisms after low-dose radiation are qualitatively different 
from high-dose mechanisms.  
 
Gene Ontology (GO) analyses (Table 1) showed that low-dose exposure of brain tissue induced 
significant biological processes, molecular functions and cellular components that were distinctly 
different from those induced after high doses, and that both doses shared some common 
functions. High-dose unique genes were preferentially associated with protein biosynthesis and 
metabolism, negative regulation of neurogenesis, RNA binding and transferase activity, and 
cellular location in mitochondria and ribosomes. The low-dose unique genes were associated 
with GTP binding, G-protein mediated signal transduction, Rho protein signal transduction, fatty 
acid binding, chromatin remodeling and various other functions associated with the activities of 
neurotransmitters and their receptors. These GO findings indicate that low-dose exposures 
11 
induced damage responses in the brain are complex and functionally diverse and significantly 
different from functions associated with high dose exposures.   
 
To understand better the differences in functions between the low- and high-dose unique genes 
(i.e., this comparison excluded the genes that were expressed in both dose groups), we performed 
bioinformatics analyses for differential pathway enrichment (Figure 1), differential gene 
interaction networks (Supplemental Material: Figures S1 and S2), and, specifically, for 
differential Tp53 and Myc effector gene interactions (Figure 2).  
 
Analyses of differential pathway enrichment (Figure 1) shows that the high-dose unique gene set 
was enriched for a few pathways including amyloid processing, oxidative stress response, 
oxidative phosphorylation, xenobiotic metabolism signaling, and Wnt/ß-catenin signaling 
(Figure 1). In contrast, the low dose-unique gene set was significantly enriched for 13 pathways 
(Figure 1) that are well known for their importance in synaptic plasticity, including axon 
guidance signaling, integrin signaling, synaptic long term depression (LTD), synaptic long term 
potentiation (LTP), G-protein coupled signaling.   
 
Analyses of gene interaction networks identified six networks for the low-dose unique gene set 
(Figure S1) and different six networks for the high-dose unique gene set (Figure S2); p-values 
for individual networks ranged from 10-52 to 10–13. Both the low- and high-dose groups of 
networks contained sub-networks with Myc and Tp53 as major nodes.  We applied differential 
pathway enrichment analyses to examine the relative functions of the genes associated with low-
dose Myc-Tp53 networks (Figure 2A, also see Figure S1) versus high-dose Myc-Tp53 networks 
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(Figure 2B, also see Figure S2). As shown in Figure 2C, the low-dose network was significantly 
enriched for SAPK/JNK signaling, estrogen receptor signaling, integrin signaling, p38 MAPK 
signaling, while the high-dose network was significantly enriched for EGF, IL-2, and IGF-1 
signaling. Both low-dose and high-dose networks were enriched for G1/S cell cycle checkpoint. 
These findings show that Tp53 and Myc affect a substantially different set of effector genes after 
low-dose exposures in contrast to high-dose exposures, and that the special signaling functions of 
the low-dose Tp53-Myc effector genes are different from the signaling functions induced after 
high-dose exposures. 
 
Analyses of the low-dose radiation genes. 
The full set of genes induced after low-dose exposure clustered into a highly saturated gene 
interaction network (Figure 3, p = 10 -53). Inspection of this saturated network identified five 
down-regulated genes associated with synaptic transmission (Grin1 and Gria3 are glutamate 
receptors genes; Nsf and Syt1 are transporters; Plat1 is a peptidase). The networks also contained 
the transcription factor, Jun, and the gene Kif1A that have both been associated with 
neurodegeneration (37). We also found that the low-dose gene set contained 10 synaptic ion 
channel genes of which 8 are down regulated (Gabrb1, Gria3, Grik5, Grin1, Kcnq2, Kcna1, 
Ryr2, Scn8A) and two are up-regulated (Fxyd1 and Scn1A). Synaptic ion channels play 
important role in synaptic plasticity (38). The transcriptional changes of several low-dose genes 
were confirmed by PCR, including the down-regulation of Grin-1 by qPCR (0.88 ± 0.07; p< 
0.05) and the up-regulation of Psma4 (Figure S1, network 3), Pcna, Csnk2a1 and Sod1 by RT-
PCR (23). 
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Pathway enrichment analysis of the low-dose unique genes (Figure 4A) was used to identify the 
pathways that were predominantly up- or down-regulated after low-dose exposures (based on the 
proportions of up- and down-regulated component genes). Only two pathways contained 
significant proportions of up-regulated genes after low-dose exposures: integrin signaling and 
SAPK/JNK signaling. In contrast, there were 13 pathways (Figure 4A) that contained 
predominantly down-regulated genes. Six of these contained only down-regulated genes 
(amyloid processing, amytrophic lateral sclerosis signaling, calcium signaling, chemokine 
signaling, glutamate receptor signaling, synaptic long term potentiation). Many of these low-dose 
down-regulated pathways are known to be associated with learning, memory and cognitive 
functions. Similar analyses of the pathways associated with up- and down-regulated high-dose 
genes (supplemental figure S3) showed a very different overall picture. Up regulated genes were 
enriched in the pathways of oxidative phosphorylation, NRF-2 mediated oxidative stress 
response, Cell cycle checkpoint regulation, protein ubiquitination, and glycine, serine, and 
threonine metabolism. Down-regulated genes were enriched in keratan sulfate biosynthesis, 
cysteine metabolism, chondroitin sulfate biosynthesis, and xenobiotic metabolism signaling. 
Amyloid processing pathway was down regulated after both low-dose (Figure 4a) and high-dose 
exposures (supplemental figure 3). 
 
Comparative analyses of transcriptional regulation in mouse brain tissue after low-dose 
irradiation against published datasets. 
Based on our pathway enrichment findings (Panel 4A), we hypothesized that low-dose radiation 
exposure may have effects on cognitive function. To inspect this hypothesis, we conducted an 
unbiased bioinforamatic survey of a compendium of datasets of transcriptional profiles of 
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various genetic and disease conditions including those from individuals with diminished 
cognitive function. Analysis with the set of up-regulated low-dose genes failed to identify any 
knowledgebase with significant expression overlap. Analyses with the set of down-regulated 
low-dose genes analyses identified two knowledgebases with significant gene overlap: the aging 
human brain and Alzheimer’s disease (Figure 4B and C). As described in the methods section, 
IPA was applied to the set of genes that was modulated in postmortem human cortex tissue from 
individuals of advanced ages up to 106 years-old (n=30, (36)) and to the gene set that was 
modulated in hippocampal tissue from Alzheimer’s patients (n= 22, (31)). Comparison of the 
relative pathway enrichments for low-dose radiation, human aging and Alzheimer’s disease gene 
expression profiles (Figure 4A, 4B and 4C) showed remarkably consistent findings not only in 
the direction of expression modulation (predominantly down-regulation), but also in the specific 
pathways involved. Six pathways were in full agreement among all data sets, and five out of six 
showed consistent down regulation.  Integrin signaling pathway was the only pathway that was 
consistently up regulated. In addition, three pathways (axonal guidance signaling, actin 
cytoskeleton signaling and ERK/MAPK signaling) were significantly affected in all three data 
sets, but they differed somewhat in the direction of their effects (up or down regulation).  
 
We then compared the component genes of the pathways that were consistently affected across 
all three data sets. Figure 5 identifies each gene of the synaptic long term depression (LTD) 
pathway whose expression was modulated in mouse brain tissue after radiation. For comparison, 
the specific genes of the LTD pathway that were affected in the aging human brain and in AD 
patients are listed in the figure legend. PRKCB1 and GRIA3 were consistently modulated in the 
LTD pathway in all three data sets. Isoforms of GNAS, a guanine nucleotide binding protein, 
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were also modulated in all three data sets (GNAS in radiation and Alzheimer’s disease; GNAQ 
in aging). Similar analyses of the down-regulated pathways of Figure 4, identified the following 
genes that were consistently down regulated across in all three data sets: MEF2C in calcium 
signaling, SLC1A1 in glutamate receptor signaling, and PRKCB1 in G-protein coupled receptor 
signaling and in synaptic long term potentiation.   
 
Figure 6 illustrates the component genes of the integrin signaling pathway, the only pathway 
consistently up regulated in all three data sets, and highlights the genes that were modulated after 
radiation exposure of the mouse brain. For comparison, the integrin pathway genes that were 
modulated in the human aging brain and in AD patients are listed in the figure legend. Two 
integrin pathway genes were affected only in the radiation and aging data sets: TLN1 and 
ACTA1. Five other integrin-related genes were affected only in the radiation and AD data sets: 
(CAPN3, CRKL, RALA, RHOQ, and ACTN3).  There were no genes that were consistently 
upregulated in all three data sets. 
 
Comparative analyses of transcriptional regulation in mouse brain tissue after high-dose 
irradiation against published datasets. 
The results of the L2L analysis of the high-dose genes showed a very different pattern than that 
of low-dose genes. The set of down-regulated high-dose genes failed to identify any expression 
knowledgebases with significant association with radiation response. However, analyses with the 
set of up-regulated high-dose genes identified the AD knowledgebase. WNT/β catenin pathway 
was marginally affected in both the high-dose radiation and AD datasets (Figure 1, Figure 4c) 
with no significant enrichment of up or down-regulated genes. Amyloid processing pathway was 
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downregulated after high-dose radiation (supplemental figure 3), and in AD (Figure 4c), as well 
as after low-dose radiation (Figure 4a), however, it did not show a significant overlap with genes 
associated with advanced human age (Figure 4b). Finally, xenobiotic metabolism was 
significantly down-regulated in the irradiated mouse brain (Figure 1 and supplemental figure 3), 
human aging (Figure 4b) and AD (Figure 4c). 
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Discussion 
Rapidly developed microarray technologies offer rich and abundant transcription profile 
information from different species, organs, condition and diseases. We have applied recent 
bioinformatics advances to understand the functions of radiation-modulated genes in the mouse 
brain, to discriminate between low- and high-dose gene networks and pathways, and to gain 
insight into the radiation damage response pathways in brain tissue by comparison with the 
damage response pathways in the aging human brain and in Alzheimer’s disease patients. 
 
Our findings demonstrate that the mechanisms of the mouse brain response within a few hours 
after low-dose exposure involves cellular damage response functions that are inherently complex 
and differ significantly from high-dose responses. The radiation response of brain tissue involves 
functions associated with Tp53 and Myc, as previously suggested by Yin et al (23) and Achanta 
et al (28). However, our bioinformatics analyses demonstrates that the Tp53–Myc associated 
effector functions after low dose are very different from those after high doses. We found that 
genes modulated after low-dose exposure are associated with common damage response 
functions and with brain-tissue specific functions associated with memory, learning and 
cognition. We also found a high degree of concordance of affected pathways in the brain tissue 
of mice after low-dose exposure, brain tissue of aging humans, and brain tissue of Alzheimer’s 
patients. High-dose exposures did not elicit any of these pathway responses. These findings 
strongly suggest that low-dose irradiation modulates the expression of gene pathways that are 
involved in cognitive function and that low-dose radiation exposure down regulates the same 
response mechanisms that are defective in aging and Alzheimer’s disease. Our analysis 
demonstrated, for the first time, that 10 cGy irradiation may have effects on cognitive function. 
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Further studies are warranted to verify the current findings using larger numbers of animals and 
at various brain regions, specifically in hippocampus, which is important for learning and 
memory. 
 
Brain radiation and cognitive function  
It is well known that high dose irradiation has detrimental effect on cognitive function (18, 28, 
39), while the information of the low-dose effect on memory is sparse. At present, the 
pathogenesis of radiation-induced cognitive injury remains unresolved. It has been speculated 
that low-dose radiation can lead to cognitive dysfunction without inducing significant 
morphological changes (40, 41). Molochkina et al (42) found that after single low-dose whole 
body gamma-irradiation (15 cGy), brain membranes functioning changed significantly as judged 
by membrane-bound acetylcholinesterase activity. Low-dose exposure is also involved in 
common-inflammatory reactions (43). Here, we demonstrated that low-dose irradiation at 10 
cGy may have effect on cognitive function through GO, network and pathway analyses.  
 
Radiation-induced cognitive impairments are generally more severe in the developing or young 
brain (44). Rola et al. (45) reported that young mice (21-day-old at the time of irradiation) 
showed persistent changes in neurogenesis, which were associated with spatial memory retention 
deficits at three months post treatment. The age of mice, at the time of radiation exposures in 
current study, was 8-to-10 weeks old, which is more equivalent to adolescent humans. Future 
studies are needed to understand the biochemical mechanisms that underlie the concordance of 
pathways we observed among low-dose radiation, aging and AD and whether the low-dose 
radiation response varies with advanced age.  
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Our analysis identifies certain cell types and cellular components of the radiation response of the 
brain. Genes associated with synapse and neuron projections are enriched after low dose whereas 
genes associated with mitochondria are enriched after high doses, and ribosomes are enriched 
after both low and high doses. This suggests that synaptic signaling is damaged after low-dose 
exposures. It also suggests that high-dose damage processing takes place in mitochondria that are 
known to be involved with apoptosis-initiating events. Unfortunately, microarray analyses based 
on large tissue volumes does not allow the resolution to determine whether our findings suggest 
a homogeneous response across all neural cells or whether the responses are specific to certain 
brain regions such as the neurogenic precursor cells (20). Further studies with microdissection 
and in situ imaging with gene probes will be required to address this question. For example, 
Lowe et al (27) employed transcript bioinformatics and in situ RNA hybridization to demonstrate 
that katamine, a glutamate receptor antagonist, modulated genes in specific cell types of the 
brain.  
 
The pathway analyses of Figure 1 emphasize the complexity of the low-dose response. Low-dose 
radiation modulate (i.e., induces or represses) the expression of genes that function in a variety of 
signaling pathways involved in axon movement and architecture (axon guidance signaling, actin 
cytoskeletal signaling), blood vessel formation (ephrin signaling), and metabolism (protein 
ubiquitination pathway, cAMP signaling, insulin receptor signaling). We provide evidence that 
the mitogen activated ERK/MAPK and stress-activated SAPK/JNK signaling pathways are 
modulated after low-dose exposures, but in different directions, ERK/MAPK was significantly 
downregulated (Figure 4A). Rho-GTPases which have an important role in activation of 
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ERK/MAPK signaling cascade (46) were preferentially and significantly modulated after low-
dose but not high-dose exposures (Table 1). SAPK/JNK, a well-known stress activated pathway 
(47) was upregulated and preferentially associated with the low-dose Tp53-Myc functions 
(Figure 2). Our findings are consistent with the report of a negative cross-talk relationship 
between the stress-activated JNK pathway and the mitogen-activated ERK pathway (48). 
 
Our network and pathway analyses showed that low-dose irradiation response involved a set of 
pathways that function in neural plasticity, memory, and learning: Glutamate receptor signaling, 
LTP, LTD, G-protein coupled receptor signaling and Integrin signaling.  The establishment of 
memory requires coordinated signaling between presynaptic and postsynaptic terminals in the 
CNS. Integrins make up a large family of cell adhesion receptors that are known to mediate 
bidirectional signaling between cells, their external environment, and have also been implicated 
in control of pathogenesis in several neurodegenerative diseases (49, 50). Recent 
pharmacological and genetic studies have suggested that beta1-integrins are critical in synaptic 
plasticity and memory formation. Chan et al. (49) reported that deletion of alpha3-integrin 
resulted in impaired LTP and the impairment in LTP and working memory is similar to that 
observed in beta1-integrin conditional knockout mice. In addition, integrins mediate beta-
amyloid-induced cell-cycle activation and neuronal death (51). In the current study, we found 
that the integrin pathway was up-regulated by low-dose exposure. 
 
The striking similarity of pathway changes among the low-dose irradiated mouse brain, human 
aging brain and AD patient brain 
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The low-dose damage response in mouse brain involves mainly down regulated genes and 
pathways, with a few exceptions (Figure 1 and 4A).  Among the 15 low-dose pathways, thirteen 
were significantly down regulated. Six of these contained down-regulated genes only. When 
these pathways were compared with those obtained in human aging brains and Alzheimer’s 
brains, it was found that six pathways have high degree of concordance (Fig. 4, A,B,C). All of 
them, except one, were down regulated in all three conditions. In addition, an example pathway 
map of LTD showed the impressive similarity of down-regulated genes in all three conditions 
(Fig. 5), with glutamate receptor gene, GRIA3 and G-protein binding gene, GNAO1 modulated 
in postsynaptic membrane region; while protein kinase C gene was down regulated in cytoplasm 
region. Haroutunian et al. (30) reported that more genes are down-regulated than up-regulated at 
any given disease severity stage in a study of 115 postmortem individuals with Alzheimer’s 
disease and dementia using microarray analysis. The disparity between up- and down-regulated 
genes became more pronounced in the advanced stages of disease. The reasons for this 
generalized gene downregulation are not obvious. Haroutunian et al. (30) hypothesized that cell 
loss or compensatory mechanisms can be invoked. Our observation of overwhelming down-
regulated network/pathways induced by low-dose exposures are in good agreement with those 
found in human aging brain and in the brains of AD patients. 
 
Strand et al. (52) compared gene expression profiles in regions of motor cortex, caudate nucleus 
and cerebellum between the healthy human and mouse using microarray. Contrasting between 
the two species, they found general similarity in region-specific gene expression patterns in 
healthy human and mouse brains. Given the fact that region-specific expression patterns of 
thousands of genes have significant correlation between the healthy human and mouse, Strand et 
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al. (52) believed that “it is reasonable to expect a high degree of concordance between 
microarray phenotypes of human neurodegenerative diseases and their mouse models”. Our 
findings are consistent with Haroutunian’s observation and Strand’s speculation. 
 
Alterations of the glutamate excitation pathway, either through reduced glutamate transport or 
aberrant expression of glutamate receptors, are known to occur during aging and Alzheimer’s 
disease (53). Our comparative analyses of transcriptional regulation in the mouse irradiated brain 
and in the human aging and Alzheimer’s brain identified 5 genes that were consistently 
downregulated across all three data sets. It is interesting to note that all five genes, GNAS (a G-
protein), GRIA3 (an AMPA glutamate receptor), SLC1A1 (a glutamate transporter), PRKCB1 (a 
protein kinase C), and MEF2C (a transcription factor), play important roles in the glutamate 
transmitter pathway, which is the major neuronal excitatory pathway in the CNS (54-56). The 
first three genes directly interact with glutamate, either as receptors (GNAS and GRIA3) or as 
transmembrane transporters (SLC1A), while PRKCB1 and MEF2 regulate AMPA receptor 
function (57) and synaptic numbers (58),  respectively. Activation of glutamate receptors is 
responsible for basal excitatory synaptic transmission and many forms of synaptic plasticity such 
as synaptic long-term potentiation (LTP) and long-term depression (LTD), which are thought to 
underlie learning and memory. This raises that tantalizing possibility that low-dose radiation may 
affect memory and cognitive function through alteration of the glutamate excitatory pathway. 
These identified genes may also represent targets for pharmaceutical intervention strategies to 
treat Alzheimer’s diseases as in the case of glutamate NMDA-receptor and its antagonist 
memantine (59). 
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Genetic studies of several of genes uniformly under-expressed in all three data sets (low-dose, 
aging, and Alzheimer’s Disease) have shown them to be involved in cognitive function. The 
protein kinase C (PKC) family of enzymes has been implicated in synaptic plasticity and 
memory in a wide range of species. PRKCB1 one of the isoforms of PKC was under expressed 
in our low-dose unique set. PKCbeta knockout mice exhibited loss of learning and suffered 
deficits in both cued and contextual fear conditioning (60). The PKC expression pattern and 
behavioral phenotype in the PKCbeta knockout animals indicate a critical role for the of 
PKCbeta isoform in learning and neural signal transduction mechanisms. The AMPA glutamate 
receptors (AMPAR) GLUR2, and GLUR3 are important for synaptic targeting/stabilization of 
AMPAR and the expression of hippocampal long-term depression (LTD). Double knock out 
mice in GLUR2 (Gria2) and GLUR 3 (Gria3) were severely impaired in basal synaptic 
transmission in vivo, demonstrating that GLUR2/3 is essential to maintain adequate synaptic 
transmission (61). Mice with homozygote mutations in Slc1a1 displayed decreases locomotor 
activity and behavioral abnormalities (62). Finally, Mef2c is a member of the Mef2 family of 
transcription factors (Mef2a-d) that are highly expressed in the brain and play key roles in the 
development and function of the nervous system (58, 63, 64). Activation of Mef2c promotes the 
transcription of a set of genes that restrict synapse number (58), while its deletion results in 
embryonic lethality (65). 
 
In summary, our findings confirm the complex nature of the brain tissue response to low-dose 
ionizing radiation, and that low-dose exposures affect many different gene pathways that are not 
utilized after doses more typically experienced in cranial radiotherapy. Our findings suggest that 
brain tissue exposed to low doses employs two broad categories of radiation damage responses: 
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(i) conserved damage response pathways such as those controlled by Tp53 and Myc functions, 
and (ii) brain-tissue specific damage response signaling pathways that are associated with neural 
function and cognition. The high concordance of affected pathways that we observed between 
low-dose radiation, aging and Alzheimer’s diseases warrants further study to determine whether 
the down regulation of these pathways after low-dose radiation is simply a transient coincidence 
of neural damage response mechanisms with no long-term consequence after low-dose 
exposures, or whether low-dose effects on these pathways portend more serious persistent 
damage to memory and cognition akin to defects seen in aging and Alzheimer’s disease.  A 
better understanding of any long term effects of low-dose exposure on cognitive function will 
have major implications for assessing neural health risks from medical radiation diagnostics, 
from side effects of radiotherapy, as well as the occupational risks to nuclear energy workers and 
to astronauts during space travel. 
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Figure Legends 
Figure 1. Comparative pathway enrichments for low-dose unique and high-dose unique 
genes.  The low- and high-dose unique genes were evaluated for pathway enrichment using IPA 
(see methods section). Significantly enriched pathways are listed on the left and their log values 
of significance are shown by the length of the colored bars (Grey for low dose; black for high 
dose). The threshold line for enrichment is p ≤ 0.05. 
 
Figure 2. Merged Tp53-Myc networks from low- and high-dose gene sets and their relative 
pathway enrichments. The unique low-dose and high-dose gene sets were assigned to 
individual gene networks (Figures S1 and S2). The two low-dose networks containing Tp53 and 
Myc were merged (top left panel) and two high-dose networks containing Tp53 and Myc were 
merged (top right panel). The genes marked with gray boxes were modulated in our microarray 
experiments after low-dose (top left) or high-dose exposures (top right). These merged networks 
were compared for relative pathway enrichment (bottom panel). The modulated genes are in 
black. Pathways that are significantly enriched in the low-dose set are shown on the left (inside 
the hatched box), while pathways that are unique to high dose are shown on the right inside 
(solid box). The threshold line for pathway enrichment is p ≤ 0.05.  
 
Figure 3. Saturated low-dose gene interaction network.  Network analyses was applied to the 
gene set containing both low-dose unique and genes that were in common between low and high 
dose exposures.  The two top networks were merged to create the saturated gene interaction 
network (p=10-53). The majority of the genes in the network, including two of the major nodes, 
are down-regulated after low-dose exposure. 
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Figure 4. Pathway enrichment analyses for the up- and down-regulated genes among three 
transcriptomic data sets: brain tissue from mice exposed to low-dose radiation (current 
study), brain tissue from aging humans, and brain tissue from Alzheimer’s disease patients. 
In each panel, the significantly enriched pathways are shown. For each pathway, the length of the 
bars shows whether the pathways were significantly down-regulated (grey bars) or up-regulated 
(black bars) with the threshold line for significance of p ≤ 0.05. The agreement of pathways 
across all three datasets is represented by three types of arrows at the right side of pathway in 
each panel. An arrow pointing upward indicates that the pathway was significantly up-regulated 
in all three datasets. An arrow pointing down indicates that the pathway was significantly down-
regulated in all three datasets. An up and down combination arrow indicates that the pathway 
was significantly modulated in all three data sets, but that direction of gene modulation was not 
the same in all three datasets. Panel A: Brain tissue from mice that received 10cGy of whole 
body radiation (unique low-dose genes, current study). Panel B: Human brain tissue from aging 
brains (36). Panel C: Hippocampal brain tissue from Alzheimer’s Disease patients (31).  
 
Figure 5. Synaptic long term depression (LTD) cascades in mouse brain tissue after low-
dose exposures in vivo. LTD is one of the most significantly down-regulated pathways in all 
three datasets. In pathway map (modified from IPA), all genes that were modulated in the mouse 
brain by exposure to ionizing radiation are shown in bold. Each bolded gene that was down-
regulated is enclosed in a rectangle, while those that were up-regulated are enclosed in hexagons. 
For comparison, in the aging human brain dataset, the following genes of this pathway map were 
down-regulated: AMPAR, ERK1/2, Gα, Gαq, PKC and PLA2. Only RYR was up-regulated in 
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the aging brain. For comparison, in the Alzheimer’s brain dataset, the following genes contained 
of this pathway map were down-regulated: AMPAR, Gα, , GUCY, IP3R, MEK1/2, PKC, PLA2 
and PP2A. Gene in this pathway map that were up-regulated in Alzheimers disease were mGlUR 
and RAS. 
 
Figure 6. Integrin cascades in mouse brain tissue after low-dose exposures in vivo. Integrin 
is the only pathway that was signficantly up-regulated in all three datasets. In this pathway map 
(modified from IPA), the genes that were modulated in the mouse brain by exposure to ionizing 
radiation are shown in bold. Genes that were down-regulated are enclosed in rectangles, while 
those that were up-regulated are enclosed in hexagons. For comparison, in the aging human brain 
dataset, the following genes contained in this pathway map were up-regulated: α-INTEGRIN, β-
INTEGRIN, CAVEOLIN, FYN, MRLC, PI3K and TALIN. Gene down-regulated were ACTIN, 
ERK1/2, MKK4, Pak and RAP. In the Alzheimer’s brain dataset, the following genes in this 
schematic were up-regulated: 7SPAN, CDC42, CRKL, RHO, RHOGAP5, and TALIN. Gene in 
this schematic that were down-regulated in Alzheimer’s disease were: ACK, ACTIN, ACTININ, 
ARF, CALPAIN, GIT and PIX. 
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SUPPLEMENTAL FIGURES. 
 
FIGURE S1: Top six low dose networks shown in order of significance. Network 1 (p=10-47), 
Network 2 (10-25), Network 3 (10-21), Network 4 (10-16 ), Network 5 & Network 6 (10 -16). Up-
regulated genes are in red, down-regulated genes in green.  
 
FIGURE S2: Top six high dose networks shown in order of significance. Network 1 (10-24), 
Network 2 (10-22), Network 3, 4, 5 & 6(10-20 ). Up-regulated genes are in red, down-regulated 
genes in green.  
 
Figure S3: Pathways with significant enrichment of up-regulated (red) and down-regulated 
(green) genes from the high-dose unique set. 
 
High Dose Low Dose Common
Unique Unique
Biological Process
protein biosynthesis 0.0001
protein metabolism 0.004
negative regulation of neurogenesis 0.0088
small GTPase mediated signal transduction 0.0059
Rho protein signal transduction 0.0002
ribosome biogenesis and assembly 0.0095
amino acid  metabolism 0.0079
DNA metabolism 0.0032
oxygen and reactive oxygen species metabolism 0.0049
Molecular Function
rRNA binding 0.0008
transferase activity 0.0042
fatty acid binding 0.0014
GTP binding 0.0019
GTPase activity 0.0003
structural constituent of ribosome 0.0007
actin binding 0.0094
transcription coactivator activity 0.0048
oxidoreductase activity 0.0027
6-phosphofructokinase activity 0.0034
electron transporter activity 0.0014
Cellular Component
mitochondrion 0.0001
synaptic vesicle 0.0045
chromatin remodeling complex(nucleoplasm) 0.0044 0.0047
synapse 0.0011
ribosome 0.007 0.0024
neuron projection 0.0005
dendrite 0.0047
secretory granule 0.0005
The GO category enrichment p-values for low and high dose unique and common set is shown above. 
Genes from chromatin remodeling complex are distributed in two groups low dose unique and in common.
Table 1. Gene Ontology analyses of biological processes, molecular functions, and cellular 
components that are significantly enriched (p values are show) in the low-dose unique, high-
dose unique and common gene sets.
Low Dose
High Dose
– log10( p-value)
Axonal Guidance Signaling
Integrin Signaling
Synaptic Long Term Depression
Actin Cytoskeleton Signaling
G-Protein Coupled Receptor Signaling
PPARa/RXRa Activation
Synaptic Long Term Potentiation
Protein Ubiquitination Pathway
Ephrin Receptor Signaling
Insulin Receptor Signaling
ERK/MAPK Signaling
cAMP-mediated Signaling
Amyloid Processing
  SAPK/INK Signaling
NRF2-mediated Oxidative Stress Response
    Oxidative Phosphorylation
Xenobiotic Metabolism Signaling
Wnt/β-catenin Signaling
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Figure 4A. Low-dose irradiated mouse brain
 Integrin Signaling
 SAPK/JNK Signaling
 Axonal Guidance Signaling
 Actin Cytoskeleton Signaling
 Synaptic Long Term Depression
 PPAR/RxRA Activation
 cAMP mediated Signaling
 G- Protein Coupled Receptor Signaling
     ERK/MAPK Signaling
                             Amyloid Processing 
Calcium Signaling
Chemokine Signaling
Glutamate Receptor Signaling
   Synaptic Long Term Potentiation
Amytrophic Lateral Sclerosis Signaling
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Figure 5 Mouse Brain: Low Dose Unique LTD pathway
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Mouse Brain: Low Dose Unique Integrin pathway
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Pathways enrichment of high-dose unique set
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